This image of Impavido (miltefosine), provided by Profunda, was rushed to Charleston in an attempt to treat a patient with primary amebic meningoencephalitis (PAM). The drug was originally developed in the 1980s by German scientists as a breast cancer treatment.
This image of Impavido (miltefosine), provided by Profunda, was rushed to Charleston in an attempt to treat a patient with primary amebic meningoencephalitis (PAM). The drug was originally developed in the 1980s by German scientists as a breast cancer treatment. Profunda
This image of Impavido (miltefosine), provided by Profunda, was rushed to Charleston in an attempt to treat a patient with primary amebic meningoencephalitis (PAM). The drug was originally developed in the 1980s by German scientists as a breast cancer treatment. Profunda

Experimental treatment has had some success fighting brain-amoeba illness

August 04, 2016 10:47 AM